Küpeli Akkol Esra, Tatlı Çankaya Irem, Şeker Karatoprak Gökçe, Carpar Elif, Sobarzo-Sánchez Eduardo, Capasso Raffaele
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Department of Pharmaceutical Botany, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
Front Pharmacol. 2021 May 13;12:669638. doi: 10.3389/fphar.2021.669638. eCollection 2021.
Psychiatric disorders are frequently encountered in many neurological disorders, such as Alzheimer's and Parkinson diseases along with epilepsy, migraine, essential tremors, and stroke. The most common comorbid diagnoses in neurological diseases are depression and anxiety disorders along with cognitive impairment. Whether the underlying reason is due to common neurochemical mechanisms or loss of previous functioning level, comorbidities are often overlooked. Various treatment options are available, such as pharmacological treatments, cognitive-behavioral therapy, somatic interventions, or electroconvulsive therapy. However oral antidepressant therapy may have some disadvantages, such as interaction with other medications, low tolerability due to side effects, and low efficiency. Natural compounds of plant origin are extensively researched to find a better and safer alternative treatment. Experimental studies have shown that phytochemicals such as alkaloids, terpenes, flavonoids, phenolic acids as well as lipids have significant potential in and models of psychiatric disorders. In this review, various efficacy of natural products in and studies on neuroprotective and their roles in psychiatric disorders are examined and their neuro-therapeutic potentials are shed light.
精神障碍在许多神经系统疾病中经常出现,如阿尔茨海默病、帕金森病以及癫痫、偏头痛、特发性震颤和中风。神经系统疾病中最常见的共病诊断是抑郁症、焦虑症以及认知障碍。无论是由于共同的神经化学机制还是先前功能水平的丧失,共病往往被忽视。有多种治疗选择,如药物治疗、认知行为疗法、躯体干预或电休克疗法。然而,口服抗抑郁药治疗可能有一些缺点,如与其他药物相互作用、因副作用导致耐受性低以及效率低。人们广泛研究植物来源的天然化合物,以寻找更好、更安全的替代治疗方法。实验研究表明,生物碱、萜类、黄酮类、酚酸以及脂质等植物化学物质在精神障碍的动物模型和细胞模型中具有显著潜力。在这篇综述中,研究了天然产物在神经保护的动物和细胞研究中的各种功效及其在精神障碍中的作用,并阐明了它们的神经治疗潜力。